Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Kezar Life Sciences, Inc. , a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer, today announced that the...

Related Keywords

,Nasdaq ,Instagram ,Facebook ,Compensation Committee ,Twitter ,Linkedin ,Kezar Life Sciences ,Kezar Life Sciences Inc ,Nasdaq Listing Rule ,Life Sciences ,